EP2945647
Ónæmisvaldandi WT-1 peptíð og aðferðir við notkun þeirra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
15.1.2014EP published:
9.9.2020EP application number:
14741142.5
EP translation filed:
8.12.2020Grant published:
15.1.2021EPO information:
European Patent Register
Max expiry date:
14.1.2034Expiry date:
14.1.2027Next due date:
31.1.2027
Title:
IMMUNOGENIC WT-1 PEPTIDES AND METHODS OF USE THEREOF
Timeline
Today
15.1.2014EP application
9.9.2020EP Publication
8.12.2020Translation submitted
15.1.2021Registration published
14.1.2027Expires
Owner
Name:
Memorial Sloan Kettering Cancer CenterAddress:
1275 York Avenue, New York, NY 10021, US
Inventor
Name:
SCHEINBERG, David A.Address:
New York, NY 10025, US
Name:
DAO, TaoAddress:
New York, NY 10128, US
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
201361752799 PDate:
15.1.2013Country:
US
Classification
Categories:
A61K 39/00, A61K 39/38
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 19.1.2021
Expires: 14.1.2022
Payer: Patice ehf.
Number: 9
Paid: 27.1.2022
Expires: 14.1.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 13.12.2022
Expires: 14.1.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 23.2.2024
Expires: 14.1.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 13.1.2025
Expires: 14.1.2026
Payer: Árnason Faktor ehf.
Number: 13
Paid: 12.1.2026
Expires: 14.1.2027
Payer: Árnason Faktor ehf.